Depression is the leading cause of disability worldwide, according to the World Health Organization — affecting more than 280 million people across every age group, income level, and background. It is also one of the most undertreated conditions in medicine, with nearly half of those who have it never receiving a diagnosis.
Part of the reason is that depression rarely looks the way people expect. The defining feature is not crying or visible sadness — it is a pervasive loss of interest, motivation, and the ability to feel pleasure. Many people living with depression describe it not as feeling bad, but as feeling nothing. Work, relationships, and daily responsibilities continue, but nothing feels meaningful, rewarding, or worth the effort.
This guide covers what depression is neurologically, every major symptom, a validated self-assessment tool, the recognized types, causes, and the full range of treatments that evidence supports.
What Is Depression?
Depression — clinically called major depressive disorder (MDD) — is a medical condition characterized by persistent changes in mood, cognition, physical function, and behavior lasting at least two weeks and causing significant impairment in daily life.
It is not a response to difficult circumstances that a person should be able to overcome through effort or attitude. Depression involves measurable changes in brain structure and function: reduced activity in the prefrontal cortex (responsible for decision-making and emotional regulation), hyperactivity in the amygdala (the brain’s threat center), and — in chronic untreated cases — reduced hippocampal volume. These are structural changes visible on neuroimaging, not character deficits.
Symptoms of Depression
Depression produces symptoms across four domains. A diagnosis of major depressive disorder requires five or more of the following, present most of the day, nearly every day, for at least two weeks — with at least one being depressed mood or loss of interest.
Emotional and cognitive symptoms:
- Persistent depressed mood — feeling sad, empty, or hopeless most of the day
- Loss of interest or pleasure in activities that were previously enjoyable (anhedonia) — often the most prominent feature
- Feelings of worthlessness or excessive guilt
- Difficulty thinking, concentrating, or making decisions
- Recurrent thoughts of death or suicide
Physical symptoms:
- Significant weight loss or gain (more than 5% of body weight in one month) without intentional dieting
- Insomnia or hypersomnia (sleeping significantly more than usual)
- Fatigue and loss of energy nearly every day
- Psychomotor agitation (restlessness, inability to sit still) or psychomotor retardation (visibly slowed movement and speech)
Physical symptoms are often the first to be noticed — and the last to be connected to depression. Fatigue, sleep changes, and appetite disruption are frequently investigated medically before the underlying mood disorder is identified.
Online Self-Assessment: The PHQ-9
The PHQ-9 (Patient Health Questionnaire-9) is the standardized screening tool used by physicians, psychiatrists, and psychologists worldwide to assess depression severity. It is not a diagnostic tool — only a licensed clinician can diagnose depression — but it provides a structured, validated framework for self-assessment.
Over the past two weeks, how often have you been bothered by the following?
Score each item: 0 = Not at all | 1 = Several days | 2 = More than half the days | 3 = Nearly every day
| # | Symptom | Your Score |
|---|---|---|
| 1 | Little interest or pleasure in doing things | 0 / 1 / 2 / 3 |
| 2 | Feeling down, depressed, or hopeless | 0 / 1 / 2 / 3 |
| 3 | Trouble falling or staying asleep, or sleeping too much | 0 / 1 / 2 / 3 |
| 4 | Feeling tired or having little energy | 0 / 1 / 2 / 3 |
| 5 | Poor appetite or overeating | 0 / 1 / 2 / 3 |
| 6 | Feeling bad about yourself — or feeling like a failure | 0 / 1 / 2 / 3 |
| 7 | Trouble concentrating on things | 0 / 1 / 2 / 3 |
| 8 | Moving or speaking unusually slowly — or being unusually restless | 0 / 1 / 2 / 3 |
| 9 | Thoughts that you would be better off dead, or of hurting yourself | 0 / 1 / 2 / 3 |
What your total score means:
| Total Score | Severity |
|---|---|
| 0 – 4 | Minimal or no depression |
| 5 – 9 | Mild depression |
| 10 – 14 | Moderate depression |
| 15 – 19 | Moderately severe depression |
| 20 – 27 | Severe depression |
Important: Any score above 0 on question 9 (thoughts of self-harm or death) warrants immediate contact with a mental health professional, regardless of total score.
Types of Depression
Major Depressive Disorder (MDD)
The most common form — episodes of significant depressive symptoms lasting at least two weeks, with full or partial recovery between episodes. A first episode doubles the risk of a second; after three episodes, recurrence risk exceeds 90% without ongoing treatment.
Persistent Depressive Disorder (Dysthymia)
A chronically depressed mood lasting at least two years, with fewer and milder symptoms than MDD but sustained duration. Often described as “always having been this way” — making it particularly underdiagnosed.
Bipolar Depression
Depressive episodes that occur within bipolar disorder. Clinically important because antidepressants used alone can trigger manic episodes in bipolar depression — making accurate diagnosis essential before treatment begins.
Postpartum Depression
A major depressive episode occurring within four weeks of delivery, though symptoms can emerge up to one year postpartum. Distinct from “baby blues” (which resolve within two weeks) in severity and duration. Affects approximately 1 in 7 women after childbirth.
Seasonal Affective Disorder (SAD)
Depressive episodes that follow a seasonal pattern — most commonly beginning in autumn or winter and remitting in spring. Light therapy (10,000 lux for 20 to 30 minutes each morning) is an evidence-based first-line treatment specific to this subtype.
Atypical Depression
A subtype characterized by mood reactivity (the ability to feel temporarily better in response to positive events — unlike classic MDD), hypersomnia, increased appetite, and a heavy leaden feeling in the limbs. Responds better to MAOIs than tricyclic antidepressants.
Causes of Depression
Depression does not have a single cause. It develops through an interaction of biological, psychological, and environmental factors.
Biological: Genetic heritability accounts for 40 to 50% of depression risk. Dysregulation of serotonin, dopamine, and norepinephrine signaling is central to the condition. Chronic inflammation — elevated inflammatory markers including CRP and IL-6 — is increasingly recognized as both a contributing cause and a consequence of untreated depression. Medical conditions including hypothyroidism, chronic pain, cardiovascular disease, and vitamin D deficiency independently increase risk.
Psychological: Negative cognitive patterns — particularly the tendency to attribute negative events to stable, global, internal causes — are both risk factors and maintaining mechanisms. Adverse childhood experiences (ACEs) including abuse, neglect, and household dysfunction significantly elevate lifetime depression risk.
Environmental: Chronic stress, grief, social isolation, financial hardship, and major life transitions are common precipitating factors. Stressful events do not cause depression in everyone — they interact with biological and psychological vulnerability.
How Depression Is Treated
Psychotherapy
Cognitive behavioral therapy (CBT) is the most extensively studied psychotherapy for depression, with response rates of 50 to 60% in mild to moderate depression. It works by identifying and restructuring the negative thought patterns that maintain depressive episodes and increasing behavioral engagement through activity scheduling.
Behavioral activation — a streamlined form of CBT focusing exclusively on increasing contact with rewarding activities — is equally effective and often more accessible. Interpersonal therapy (IPT) is particularly effective when depression is linked to grief or relationship difficulties.
Medication
SSRIs (sertraline, escitalopram, fluoxetine) are first-line for moderate to severe depression — increasing serotonin availability and reducing amygdala hyperreactivity over four to six weeks.
SNRIs (venlafaxine, duloxetine) address both serotonin and norepinephrine — useful when low energy and physical symptoms are prominent.
Bupropion targets dopamine and norepinephrine rather than serotonin — preferred when anhedonia, low motivation, and fatigue are the dominant symptoms, and when sexual side effects from SSRIs are a concern.
Mirtazapine is particularly suited to depression with insomnia and appetite loss — its sedating and appetite-stimulating properties are therapeutically useful in this profile.
Combined Treatment
Psychotherapy combined with medication consistently outperforms either treatment alone in moderate to severe depression — the combination produces response rates of 60 to 70% compared to approximately 50% for either alone.
Advanced Treatments
For treatment-resistant depression (failure of two adequate medication trials), evidence-based options include:
- Transcranial magnetic stimulation (TMS): Non-invasive brain stimulation approved by the FDA for treatment-resistant depression
- Electroconvulsive therapy (ECT): The most effective treatment for severe, refractory, or psychotic depression — with response rates above 80%
- Esketamine (Spravato): FDA-approved intranasal treatment for treatment-resistant depression, with rapid onset within hours
Lifestyle
Regular aerobic exercise (150 minutes per week) produces clinically meaningful antidepressant effects — comparable to medication in mild to moderate depression in multiple controlled trials. Consistent sleep, social connection, reduced alcohol use, and omega-3 supplementation (1 to 2 g EPA+DHA daily) are meaningful adjuncts to primary treatment.
When to Seek Help
Seek evaluation from a doctor or mental health professional if: you have experienced five or more of the listed symptoms for two or more weeks; symptoms are interfering with work, relationships, or daily function; you scored 10 or above on the PHQ-9; or you have any thoughts of self-harm or suicide.
If you are experiencing thoughts of suicide or self-harm right now, contact your local emergency services or a crisis helpline immediately. In the United States, call or text 988 to reach the Suicide and Crisis Lifeline, available 24 hours a day.
This article is for informational purposes only and does not replace professional medical or mental health advice. The PHQ-9 self-assessment is a screening tool, not a diagnostic instrument. Depression diagnosis and treatment must be conducted by a licensed healthcare provider or qualified mental health professional. If you are in crisis, seek emergency help immediately.
